Treatment considerations for elderly and frail patients with neuropathic pain.
Mayo Clinic Proceedings, 2010
schma001@mc.duke.edu Currently, an estimated 38 million individuals 65 years or older live in the United States, and more than 11 million of these individuals are 80 years or older.
Older people are at high risk of neuropathic pain because many diseases that cause neuropathic pain increase in incidence with age.
Depending on their underlying health, older adults with neuropathic pain may have to cope with multiple coexisting diseases, polypharmacy, and impaired functional ability.
The objective of this article is to review how aging and frailty affect the treatment of older adults with neuropathic pain.
Specific topics reviewed include the complexity of treatment decisions in older patients due to aged heterogeneity, multimorbidity, and polypharmacy; selection of treatment in an effort to maximize patients' functional abilities in addition to relieving their pain; more careful dosing (usually lower) and monitoring of pharmacotherapy relative to younger patients due to age-related changes in pharmacokinetics and pharmacodynamics; and underrepresentation of older adults in clinical trials of neuropathic pain treatments, which further compromises physicians' ability to make informed treatment decisions.
View rest of article at www.ncbi.nlm.nih.gov «
Related articles
Below are some of our articles related to the article above:
The TRIP Database is a clinical search tool designed to allow health professionals to rapidly identify the highest quality clinical evidence for clinical practice.
Registered users (registration is free) benefit from extra features such as CPD, search history, and collaborative tools. Register here, or Login if you have registered before.
Find out more about Trip Database.
